Shares of Cepheid rose 7.5 percent for the five-day trading period ended Tuesday. The trading week was cut short a few hours on Tuesday in advance of the Independence Day holiday in the US.
Cepheid and Becton Dickinson were mentioned in an article in Friday’s edition of The Wall Street Journal focused on new testing methods for antibiotic resistance in hospitals. The firms make the only Food and Drug Administration-cleared molecular-based tests for methicillin-resistant Streptococcus aureus.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.